Tristel Investors
Tristel is a leading manufacturer of infection control, contamination control, and hygiene products. Founded in 1993, the company developed a proprietary chlorine dioxide formulation to replace toxic disinfectants used in hospitals. Over the years, Tristel has captured significant market share in the UK hospital market and expanded its vision to apply its chemistry to various vectors of infection transmission. The company's key milestone was the establishment of a manufacturing plant in Cambridgeshire in 2007. Tristel offers a comprehensive solution for the decontamination of medical devices, including a reusable tourniquet and digital traceability for its products. With a focus on efficacy, reliability, and speed, Tristel aims to provide an effective and reliable solution for infection prevention in various medical settings.
Technology:
Investors
Headquarters:
Snailwell, Cambridgeshire, United Kingdom
Founded Date:
1998
Employees Number:
250
Investor Type:
Healthcare Company
Register and Claim Ownership